Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety - PubMed (original) (raw)
Review
. 2010 Oct;235(10):1163-7.
doi: 10.1258/ebm.2010.009331.
Affiliations
- PMID: 20881320
- DOI: 10.1258/ebm.2010.009331
Review
Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety
Annika Thorsell. Exp Biol Med (Maywood). 2010 Oct.
Abstract
Neuropeptides such as neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH) have been implicated not only in acute regulation of stress/anxiety-related behaviors, but adaptations and changes in these neuropeptide systems may also participate in the regulation of behavior and endocrine responses during chronic stress. NPY is an endogenous anxiolytic neuropeptide, while CRH has anxiogenic properties upon central administration. Changes in these neuropeptide systems may contribute to disease states and give us indications for putative treatment targets for stress/anxiety disorders as well as alcohol/drug dependence. In this review, we briefly present these two systems and review their involvement in mediating the responses to acute and chronic stressors, as well as their possible roles in the development and progression of stress/anxiety disorders. We suggest that neuropeptides may be attractive in treatment development for stress/anxiety disorders, as well as for alcohol/drug dependence, based on their specificity and activity following exposure to external challenges, i.e. stressors, and their differential adaptations during transition from an acute to a chronic stress exposure state.
Similar articles
- Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
Valdez GR, Koob GF. Valdez GR, et al. Pharmacol Biochem Behav. 2004 Dec;79(4):671-89. doi: 10.1016/j.pbb.2004.09.020. Pharmacol Biochem Behav. 2004. PMID: 15582675 Review. - Interactions between NPY and CRF in the amygdala to regulate emotionality.
Sajdyk TJ, Shekhar A, Gehlert DR. Sajdyk TJ, et al. Neuropeptides. 2004 Aug;38(4):225-34. doi: 10.1016/j.npep.2004.05.006. Neuropeptides. 2004. PMID: 15337374 Review. - Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake.
Thorsell A. Thorsell A. Ann N Y Acad Sci. 2008 Dec;1148:136-40. doi: 10.1196/annals.1410.083. Ann N Y Acad Sci. 2008. PMID: 19120101 Review. - Neuropeptide Y and sleep.
Dyzma M, Boudjeltia KZ, Faraut B, Kerkhofs M. Dyzma M, et al. Sleep Med Rev. 2010 Jun;14(3):161-5. doi: 10.1016/j.smrv.2009.09.001. Epub 2010 Feb 1. Sleep Med Rev. 2010. PMID: 20122859 Review.
Cited by
- Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.
Fischler PV, Soyka M, Seifritz E, Mutschler J. Fischler PV, et al. Front Pharmacol. 2022 Oct 3;13:927703. doi: 10.3389/fphar.2022.927703. eCollection 2022. Front Pharmacol. 2022. PMID: 36263121 Free PMC article. Review. - Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice.
Reichmann F, Hassan AM, Farzi A, Jain P, Schuligoi R, Holzer P. Reichmann F, et al. Sci Rep. 2015 Jun 12;5:9970. doi: 10.1038/srep09970. Sci Rep. 2015. PMID: 26066467 Free PMC article. - A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.
Bell RL, Hauser S, Rodd ZA, Liang T, Sari Y, McClintick J, Rahman S, Engleman EA. Bell RL, et al. Int Rev Neurobiol. 2016;126:179-261. doi: 10.1016/bs.irn.2016.02.017. Epub 2016 Mar 21. Int Rev Neurobiol. 2016. PMID: 27055615 Free PMC article. Review. - PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3.
Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, Xue YX, Ding ZB, Shi J, Lu L. Shi HS, et al. Neuropsychopharmacology. 2012 Nov;37(12):2671-83. doi: 10.1038/npp.2012.131. Epub 2012 Jul 25. Neuropsychopharmacology. 2012. PMID: 22828749 Free PMC article. - Aplysia Locomotion: Network and Behavioral Actions of GdFFD, a D-Amino Acid-Containing Neuropeptide.
Yang CY, Yu K, Wang Y, Chen SA, Liu DD, Wang ZY, Su YN, Yang SZ, Chen TT, Livnat I, Vilim FS, Cropper EC, Weiss KR, Sweedler JV, Jing J. Yang CY, et al. PLoS One. 2016 Jan 21;11(1):e0147335. doi: 10.1371/journal.pone.0147335. eCollection 2016. PLoS One. 2016. PMID: 26796097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous